These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32087087)

  • 1. Global miRNA and mRNA expression profiles identify miRNA-26a-2-3p-dependent repression of IFN signature in systemic sclerosis human monocytes.
    Ciechomska M; Wojtas B; Swacha M; Olesinska M; Benes V; Maslinski W
    Eur J Immunol; 2020 Jul; 50(7):1057-1066. PubMed ID: 32087087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
    Mariotti B; Servaas NH; Rossato M; Tamassia N; Cassatella MA; Cossu M; Beretta L; van der Kroef M; Radstake TRDJ; Bazzoni F
    Front Immunol; 2019; 10():100. PubMed ID: 30804934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
    van der Kroef M; Castellucci M; Mokry M; Cossu M; Garonzi M; Bossini-Castillo LM; Chouri E; Wichers CGK; Beretta L; Trombetta E; Silva-Cardoso S; Vazirpanah N; Carvalheiro T; Angiolilli C; Bekker CPJ; Affandi AJ; Reedquist KA; Bonte-Mineur F; Zirkzee EJM; Bazzoni F; Radstake TRDJ; Rossato M
    Ann Rheum Dis; 2019 Apr; 78(4):529-538. PubMed ID: 30793699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
    Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
    Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive microRNA and transcriptomic profiling of rheumatoid arthritis monocytes: role of microRNA-146b in pro-inflammatory progression.
    Ciechomska M; Wojtas B; Bonek K; Roszkowski L; Gluszko P; Benes V; Maslinski W
    Rheumatology (Oxford); 2021 Nov; 60(11):5424-5435. PubMed ID: 34009317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes.
    Ciechomska M; Roszkowski L; Burakowski T; Massalska M; Felis-Giemza A; Roura AJ
    Front Immunol; 2023; 14():980247. PubMed ID: 37056771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific microRNA/mRNA expression profiles and novel immune regulation mechanisms are induced in THP-1 macrophages by in vitro exposure to Trichosporon asahii.
    Zhang M; Xia Z; Yang X; Ao J; Yang R
    Mycoses; 2021 Aug; 64(8):831-840. PubMed ID: 33715213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients.
    Zhou B; Zuo XX; Li YS; Gao SM; Dai XD; Zhu HL; Luo H
    Sci Rep; 2017 Feb; 7():42899. PubMed ID: 28211533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis.
    Rossato M; Affandi AJ; Thordardottir S; Wichers CGK; Cossu M; Broen JCA; Moret FM; Bossini-Castillo L; Chouri E; van Bon L; Wolters F; Marut W; van der Kroef M; Silva-Cardoso S; Bekker CPJ; Dolstra H; van Laar JM; Martin J; van Roon JAG; Reedquist KA; Beretta L; Radstake TRDJ
    Arthritis Rheumatol; 2017 Sep; 69(9):1891-1902. PubMed ID: 28556560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.
    Rudnik M; Rolski F; Jordan S; Mertelj T; Stellato M; Distler O; Blyszczuk P; Kania G
    Arthritis Rheumatol; 2021 Sep; 73(9):1720-1730. PubMed ID: 33760395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects.
    Avenoso A; Campo S; Scuruchi M; Mania M; Innao V; D'Ascola A; Mandraffino G; Allegra AG; Musolino C; Allegra A
    Pathol Res Pract; 2021 Feb; 218():153317. PubMed ID: 33360970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis.
    Villanueva-Martin G; Acosta-Herrera M; Carmona EG; Kerick M; Ortego-Centeno N; Callejas-Rubio JL; Mages N; Klages S; Börno S; Timmermann B; Bossini-Castillo L; Martin J
    J Autoimmun; 2023 Nov; 140():103097. PubMed ID: 37633117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts.
    Alsaleh G; François A; Philippe L; Gong YZ; Bahram S; Cetin S; Pfeffer S; Gottenberg JE; Wachsmann D; Georgel P; Sibilia J
    PLoS One; 2014; 9(10):e111266. PubMed ID: 25360821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.
    Steen SO; Iversen LV; Carlsen AL; Burton M; Nielsen CT; Jacobsen S; Heegaard NH
    J Rheumatol; 2015 Feb; 42(2):214-21. PubMed ID: 25399392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
    Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
    Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion.
    Servaas NH; Mariotti B; van der Kroef M; Wichers CGK; Pandit A; Bazzoni F; Radstake TRDJ; Rossato M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-29: a potential therapeutic target for systemic sclerosis.
    Peng WJ; Tao JH; Mei B; Chen B; Li BZ; Yang GJ; Zhang Q; Yao H; Wang BX; He Q; Wang J
    Expert Opin Ther Targets; 2012 Sep; 16(9):875-9. PubMed ID: 22793265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNA-5196 in the pathogenesis of systemic sclerosis.
    Ciechomska M; Zarecki P; Merdas M; Swierkot J; Morgiel E; Wiland P; Maslinski W; Bogunia-Kubik K
    Eur J Clin Invest; 2017 Aug; 47(8):555-564. PubMed ID: 28639412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.